BonAlive Biomaterials Gets CE Mark for BonAlive Putty

BonAlive Biomaterials Ltd (Turku, Finland) has been awarded CE Mark approval for its BonAlive Putty, a bone graft substitute indicated for treatment of bony voids and gaps. The putty builds on their current osteostimulative S53P4 bioactive glass gran...

Source: Medgadget - November 25, 2013 Category: Technology Consultants Authors: Nishey Wanchoo Tags: Orthopedic Surgery Source Type: blogs